Asterias Biotherapeutics Receives $11.7M in Proceeds from Exercise of Warrants
May 26, 2015 at 09:41 AM EDT
Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a biotechnology company focused on the emerging field of regenerative medicine, today ...